 |
|
Search or browse SRF's database of citations. Citations are retrieved from PubMed and updated weekly (usually on Fridays) using these search terms. We include papers on schizophrenia and related diseases, as well as relevant basic science. Citations go back to the year 2000. Please advise us of papers we have missed.
|
 |
|
Search SRF Papers |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
Current Papers: Week of 7-13 June 2013
|
 |
 |
 |
 |
 |
1 to 20 of 109 results |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Thornton LK, Baker AL. The importance of investigating alcohol use among people with schizophrenia. Acta Psychiatr Scand.
2013 Jul ;128(1):96.
PubMed Abstract
|
 |
 |
 |
 |
 |
Steinhausen HC, Bisgaard C. Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark. Acta Psychiatr Scand.
2013 Jun 6;
PubMed Abstract
|
 |
 |
 |
 |
 |
Akin S, Bahat G, Tufan F, Saka B, Oztop N, Erten N, Karan MA. Olanzapine as a cause of peripheric edema in an elderly man. Aging Clin Exp Res.
2013 Apr ;25(1):115-7.
PubMed Abstract
|
 |
 |
 |
 |
 |
Filippi M, Canu E, Gasparotti R, Agosta F, Valsecchi P, Lodoli G, Galluzzo A, Comi G, Sacchetti E. Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. AJNR Am J Neuroradiol.
2013 Jun 6;
PubMed Abstract
|
 |
 |
 |
 |
 |
Reavley NJ, Morgan AJ, Jorm AF. Development of scales to assess mental health literacy relating to recognition of and interventions for depression, anxiety disorders and schizophrenia/psychosis. Aust N Z J Psychiatry.
2013 Jun 6;
PubMed Abstract
|
 |
 |
 |
 |
 |
Hahn L, Rigby A, Galletly C. Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia. Aust N Z J Psychiatry.
2013 Jun 5;
PubMed Abstract
|
 |
 |
 |
 |
 |
Jorm AF. Treatment to reduce risk of psychosis: The need to consider the potential harms as well as the benefits. Aust N Z J Psychiatry.
2013 Jun 6;
PubMed Abstract
|
 |
 |
 |
 |
 |
Liu X, Lai Y, Wang X, Hao C, Chen L, Zhou Z, Yu X, Hong N. Reduced white matter integrity and cognitive deficit in never-medicated chronic schizophrenia: A diffusion tensor study using TBSS. Behav Brain Res.
2013 Jun 6;
PubMed Abstract
|
 |
 |
 |
 |
 |
Vilardaga R, Hayes SC, Atkins DC, Bresee C, Kambiz A. Comparing experiential acceptance and cognitive reappraisal as predictors of functional outcome in individuals with serious mental illness. Behav Res Ther.
2013 May 2;51(8):425-433.
PubMed Abstract
|
 |
 |
 |
 |
 |
Khadka S, Meda SA, Stevens MC, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, O'Neil K, Schretlen D, Pearlson GD. Is Aberrant Functional Connectivity A Psychosis Endophenotype? A Resting State Functional Magnetic Resonance Imaging Study. Biol Psychiatry.
2013 Jun 5;
PubMed Abstract
|
 |
 |
 |
 |
 |
Yu DX, Marchetto MC, Gage FH. Therapeutic Translation of iPSCs for Treating Neurological Disease. Cell Stem Cell.
2013 Jun 6;12(6):678-88.
PubMed Abstract
|
 |
 |
 |
 |
 |
Arentsen TJ, Boone KB, Lo TT, Goldberg HE, Cottingham ME, Victor TL, Ziegler E, Zeller MA. Effectiveness of the Comalli Stroop Test as a Measure of Negative Response Bias. Clin Neuropsychol.
2013 Jun 7;
PubMed Abstract
|
 |
 |
 |
 |
 |
Hoeben E, Neyens M, Mannaert E, Schmidt M, Vermeulen A. Population Pharmacokinetics of JNJ-37822681, a Selective Fast-Dissociating Dopamine D2-Receptor Antagonist, in Healthy Subjects and Subjects with Schizophrenia and Dose Selection Based on Simulated D2-Receptor Occupancy. Clin Pharmacokinet.
2013 Jun 11;
PubMed Abstract
|
 |
 |
 |
 |
 |
Ottavi P, D'Alia D, Lysaker P, Kent J, Popolo R, Salvatore G, Dimaggio G. Metacognition-Oriented Social Skills Training for Individuals with Long-Term Schizophrenia: Methodology and Clinical Illustration. Clin Psychol Psychother.
2013 Jun 11;
PubMed Abstract
|
 |
 |
 |
 |
 |
Awad AG, Voruganti LN. The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia. CNS Drugs.
2013 Jun 12;
PubMed Abstract
|
 |
 |
 |
 |
 |
Celada P, Bortolozzi A, Artigas F. Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research. CNS Drugs.
2013 Jun 12;
PubMed Abstract
|
 |
 |
 |
 |
 |
Vieta E, Valentí M. Pharmacological Management of Bipolar Depression: Acute Treatment, Maintenance, and Prophylaxis. CNS Drugs.
2013 Jun 9;
PubMed Abstract
|
 |
 |
 |
 |
 |
Keating GM. Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia. CNS Drugs.
2013 Jun ;27(6):479-89.
PubMed Abstract
|
 |
 |
 |
 |
 |
Assunção Leme IB, Gadelha A, Sato JR, Kiyomi Ota V, de Jesus Mari J, Melaragno MI, de Arruda Cardoso Smith M, Nogueira Belangero SI, Bressan RA, Jackowski AP. Is there an association between cortical thickness, age of onset, and duration of illness in schizophrenia? CNS Spectr.
2013 Jun 6;:1-7.
PubMed Abstract
|
 |
 |
 |
 |
 |
Thoresen C, Endestad T, Sigvartsen NP, Server A, Bolstad I, Johansson M, Andreassen OA, Jensen J. Frontotemporal hypoactivity during a reality monitoring paradigm is associated with delusions in patients with schizophrenia spectrum disorders. Cogn Neuropsychiatry.
2013 Jun 11;
PubMed Abstract
|
 |
 |
 |
 |
 |
 |
1 to 20 of 109 results |
|
|
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
SRF News
SRF Comments
Text Size  
Reset Text Size
Email this page
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
Watch NIH Videocasts!
Navigating the Cellular Landscape With New Imaging Strategies: Wednesday, June 12, 2013, 3:00 p.m.
DNA Repair Young Investigator Lectures 2013: Tuesday, June 18, 2013, 12:30 p.m.
Synaptic Modulation by Activity and Neurotrophins: Wednesday, June 19, 2013, 3:00 p.m.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
See our most recent Schizophrenia Bulletin theme Webinar: Taking Stock of Glutamate in Schizophrenia, held 5 February 2013.
Check out our Schizophrenia Bulletin theme Webinar: Neurotropic Infectious Agents and Cognitive Impairment in Schizophrenia, held 13 November 2012.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |